AIM in Health Affairs Forefront
Authors from 3 organizations, including AIM, published Priorities and Policy Levers to Support School-Located Vaccination in Health Affairs Forefront.
How Can Faith Leaders Help Support the COVID-19 Vaccination Effort?
This resource provides faith-based organizations with tools to assist in stopping the spread of COVID-19.
AIM in the Council of Public Health Nursing Organizations Blog
(CPHNO) published a blog post on school nurses' impact in promoting vaccine confidence and utilized AIM resources in the article.
How Can Community-Based Organizations Help Support the COVID-19 Vaccination Effort?
This resource provides community-based organizations (CBOs) with tools to assist in stopping the spread of COVID-19.
How to Keep Communities Engaged in the Fight Against Flu As We Combat COVID-19
This iREACH webinar featured information presented by our Subject Matter Experts on a variety of topics related to flu disease and flu vaccine,…
Social Media Resources from the Community COVID Coalition
The Community COVID Coalition, a project of the CDC Foundation, hosted a webinar on January 20, “COVID-19 and Social Media: Best Practices to Reach Your Communities”.
Engaging Rural Pharmacies to Increase Vaccine Access and Confidence Webinar
AIM hosted Engaging Rural Pharmacies to Increase Vaccine Access and Confidence Webinar with Laura Lee Hall, Ph.D., President of the Center for Sustainable Health Care Quality and Equity.
AIM and NASN SLV Special Supplement
AIM and the National Association of School Nurses (NASN) are excited to share the NASN School Nurse January 2022 Special Supplement “School-Located Vaccination (SLV) Clinics in the Era of COVID-19.”
COVID-19 Vaccine Update and Updated Quarantine/Isolation Recommendations
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.